Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
20.20
+0.58 (2.96%)
Nov 22, 2024, 4:00 PM EST - Market closed
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.60 billion as of November 22, 2024. Its market cap has increased by 148.42% in one year.
Market Cap
1.60B
Enterprise Value
1.06B
1-Year Change
148.42%
Ranking
Category
Stock Price
$20.20
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.60B, an increase of 4,511.23%. That is a compound annual growth rate of 44.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.57B | 36.87% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.62B |
| 10x Genomics | 1.61B |
| Nurix Therapeutics | 1.60B |
| Dynavax Technologies | 1.60B |
| Neumora Therapeutics | 1.58B |
| Arvinas | 1.56B |
| Travere Therapeutics | 1.55B |
| Teladoc Health | 1.55B |